Open Access Green as soon as Postprint is submitted to ZB.
Biological monitoring of welders exposed to aluminium.
Toxicol. Lett. 162, 239-245 (2006)
To evaluate an adequate strategy for biological monitoring of aluminium (Al), a group of 62 Al welders (age in 1999: 23-51 years, median 35 years) was surveyed annually from 1999 to 2003 by determination of pre- and post-shift Al in urine and plasma. Biomonitoring was supplemented by personal air measurements of the total dust concentration. The welders' internal exposure was compared to the exposure of 60 non-exposed assembly workers (age in 1999: 21-51 years, median: 36 years) who were surveyed in 1999, 2001 and 2003. Having a nearly constant dust exposure, median concentrations of Al in urine (Al in plasma) of the welders decreased from 40.1 μg/g to 19.8 μg/g creatinine (8.7 to 4.6 μg/l). For the control group the median levels of Al in urine (plasma) ranged from 4.8 μg/g to 5.2 μg/g creatinine (2.4-4.3 μg/l) indicating a higher sensitivity for the marker Al in urine. No systematic differences have been found between pre- and post-shift internal exposure. This might be caused by the slow elimination kinetics and low systemic bioavailability of Al. A correlation analysis did not yield close relationships between dust exposure, Al in plasma and Al in urine underlining the importance of biomonitoring for assessment of Al exposure. © 2005 Elsevier Ireland Ltd. All rights reserved.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
2.430
0.000
16
30
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
aluminium; aluminium welders; biomonitoring; welding fumes
Language
english
Publication Year
2006
HGF-reported in Year
2006
ISSN (print) / ISBN
0378-4274
e-ISSN
1879-3169
Journal
Toxicology Letters
Quellenangaben
Volume: 162,
Issue: 2-3,
Pages: 239-245
Publisher
Elsevier
Publishing Place
Amsterdam
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Enabling and Novel Technologies
PSP Element(s)
G-505200-002
Scopus ID
32644445907
Erfassungsdatum
2006-10-13